S

SK Life Science

Develops CNS and cancer therapies

Director Clinical Pharmacology

Quantitative Biology & BiostatisticsPosted on Nov 5
Full-timeParamus, NJ, USAIn-person

About the Job

Requirements

  • A PhD or PharmD degree in Pharmaceutical Sciences or a related discipline is required.
  • At least 7 years of industry experience and a proven track record in the stated duties are required, with a background in pharmacokinetics and pharmacodynamics.
  • Previous experience leading clinical pharmacology programs is required.
  • Highly skilled in compartmental and non-compartmental analyses.
  • Excellent writing and verbal communication skills are required.
  • Ability to work in a matrix environment with different leadership styles is required.
  • Ability to work independently, proactively, and effectively is required.
  • Ability to multitask is required.
  • Ability to adapt to change is required.
  • Ability to maintain composure under pressure is required.
  • Ability to follow verbal or written instructions and communicate effectively is required.
  • Ability to examine and observe details is required.

Responsibilities

  • Act as the clinical pharmacology representative, providing expertise to multidisciplinary study teams for one or more early- and late-stage clinical and lifecycle-management projects or programs.
  • Support the design and interpretation of Phase 1 and other clinical studies or programs that include pharmacokinetic or pharmacokinetic/pharmacodynamic data.
  • Perform non-compartmental analysis of pharmacokinetic data and ensure appropriate pharmacokinetic/pharmacodynamic analyses, including population pharmacokinetic or pharmacokinetic/pharmacodynamic modeling and simulation.
  • Contribute to the appropriate design of clinical study protocols and review of clinical study reports.
  • Contribute to the selection of Phase 1 contract research organizations.
  • Participate in dose selection for Phase 1, Phase 2, and Phase 3 clinical studies.
  • Work with preclinical, statistics, clinical operations, medical director, and regulatory affairs colleagues, and internal and external partners, to complete clinical studies and regulatory filings on time.
  • Represent the clinical pharmacology group on multidisciplinary study and project teams.
  • Own and contribute clinical pharmacology components to regulatory documents, including investigational new drug applications, new drug applications, and investigator brochures, as needed.
  • Act as the clinical study lead for all clinical pharmacology and Phase 1 studies.
  • Provide expertise and support for the design, execution, interpretation, and reporting of clinical pharmacokinetic/pharmacodynamic studies.
  • Participate in selecting Phase 1 contract research organizations for clinical pharmacology studies.
  • Ensure preclinical characterization is adequate and support characterization of a compound's clinical pharmacology profile.
  • Ensure clinical pharmacology strategies and plans support selection of doses and regimens for Phase 1, Phase 2, and Phase 3 studies.
  • Contribute to planning, writing, implementation, and organization of regulatory filings, and present pharmacokinetic/pharmacodynamic data to internal cross-functional teams and external collaborators.
  • Provide oversight of and be responsible for pharmacometric analyses and activities supporting a compound's clinical pharmacology profile, as applicable.

Desired Qualifications

  • Working knowledge of NONMEM and R is preferred.

About the Company

SK Life Science

Develops CNS and cancer therapies

SK Life Science is a U.S. subsidiary focused on developing medicines for central nervous system (CNS) disorders and cancer. Its work centers on researching and bringing pharmaceutical treatments to market that address neurological diseases and oncology, leveraging the broader SK Group’s resources and expertise. The company’s products work by targeting disease mechanisms in CNS conditions or cancer, delivered through conventional pharmaceutical formulations developed through its science-driven pipeline (as part of SK Biopharmaceuticals). What sets SK Life Science apart from competitors is its backing by SK Group and SK Biopharmaceuticals, enabling strong research, development, and global scale, as well as a stated commitment to real patient impact in CNS and oncology. The company aims to transform lives by delivering meaningful treatments that improve outcomes for patients with CNS disorders and cancer.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Paramus, NJ
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at SK Life Science

See more jobs